HomeCompareVRTK vs MRK

VRTK vs MRK: Dividend Comparison 2026

VRTK yields 97.56% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRTK wins by $3.47M in total portfolio value
10 years
VRTK
VRTK
● Live price
97.56%
Share price
$2.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.52M
Annual income
$1,168,366.03
Full VRTK calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — VRTK vs MRK

📍 VRTK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRTKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRTK + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRTK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRTK
Annual income on $10K today (after 15% tax)
$8,292.68/yr
After 10yr DRIP, annual income (after tax)
$993,111.13/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, VRTK beats the other by $984,514.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRTK + MRK for your $10,000?

VRTK: 50%MRK: 50%
100% MRK50/50100% VRTK
Portfolio after 10yr
$1.79M
Annual income
$589,239.90/yr
Blended yield
32.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VRTK
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRTK buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRTKMRK
Forward yield97.56%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$3.52M$57.7K
Annual income after 10y$1,168,366.03$10,113.78
Total dividends collected$3.14M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VRTK vs MRK ($10,000, DRIP)

YearVRTK PortfolioVRTK Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,456$9,756.10$11,213$373.04+$9.2KVRTK
2$40,540$18,651.56$12,667$512.06+$27.9KVRTK
3$77,923$34,545.21$14,439$708.14+$63.5KVRTK
4$145,434$62,056.61$16,640$988.16+$128.8KVRTK
5$263,859$108,244.60$19,432$1,394.07+$244.4KVRTK
6$465,868$183,539.14$23,057$1,992.90+$442.8KVRTK
7$801,335$302,856.10$27,889$2,894.79+$773.4KVRTK
8$1,344,288$486,859.57$34,518$4,286.29+$1.31MVRTK
9$2,201,693$763,305.13$43,912$6,494.35+$2.16MVRTK
10$3,524,178$1,168,366.03$57,714$10,113.78+$3.47MVRTK

VRTK vs MRK: Complete Analysis 2026

VRTKStock

VarTech Systems Inc. manufactures and sells LCD flat panel displays, industrial monitors, computers, workstations, and HMI panel mount computer solutions. Its products include touch screens, industrial monitors and computers, industrial panels and enclosures, public access kiosks, mobile computers, small form factor IPCs, systems for mission critical applications, sunlight readable display monitors, and solutions for the harshest indoor locations and outdoor environments. The company also provides hazardous area, explosion-proof, and non-incendive computer products and panel PCs. In addition, it offers CRT/LCD repair and replacement services. The company provides its products in various industrial areas, such as mining, marine vessels, oil and gas, food processing, pharmaceutical, vehicle mount applications, transportation, control processing, and automation. VarTech Systems Inc. was founded in 1988 and is based in Baton Rouge, Louisiana.

Full VRTK Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VRTK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRTK vs SCHDVRTK vs JEPIVRTK vs OVRTK vs KOVRTK vs MAINVRTK vs JNJVRTK vs ABBVVRTK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.